Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-011636

Director sold 18,167 shares at $12.12 ($220,246)

From the SEC's structured data for this filing

Trades in this filing

Kauffman Michael · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-17 Sale : show line 1 in the form −9,079 $12.12 $110,068 698,983 D
2022-02-17 Sale : show line 2 in the form −9,088 $12.12 $110,177 904,357 I
Open-market sales · 18,167 sh · avg $12.12 · $220,246
Loading xslF345X03/doc4.xml…